tb_pressreleaselogo.png
Taglich Brothers Initiates Coverage of BioSig Technologies, Inc.
September 16, 2022 09:30 ET | Taglich Brothers Inc
NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Taglich Brothers, Inc. announces it has initiated coverage of BioSig Technologies, Inc. (NASDAQ: BSGM). BioSig Technologies, Inc., headquartered in...
InCarda Logo.png
InCarda Therapeutics Announces Enrollment of First Patient in Pivotal Phase 3 RESTORE-1 Trial of InRhythm™ for the Treatment of Paroxysmal Atrial Fibrillation
July 26, 2022 07:00 ET | InCarda Therapeutics, Inc.
Single Pivotal Phase 3 Trial to Support Filing of New Drug Application Positive Phase 2 Efficacy and Safety Data for InRhythm Recently Highlighted as “Editor’s Pick” in Circulation: Arrhythmia...
logo 600X600.png
Global Extracorporeal Membrane Oxygenation System Market to Surpass US$ 476.8 Million by 2030, Says Coherent Market Insights (CMI)
July 12, 2022 09:10 ET | CMI
Seattle, July 12, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global extracorporeal membrane oxygenation system market is estimated to be valued at US$ 316.5 million in 2022...
DBMR Logo.png
Cardiac Safety Services Market Explores New Growth Opportunities at a CAGR of 15.4% till 2029: Industry Share, Growth, Demand, Size, Trends and Forecast 2022 To 2029
May 26, 2022 08:56 ET | Data Bridge Market Research
FLORIDA, United States, May 26, 2022 (GLOBE NEWSWIRE) -- The latest study released on the Global Cardiac Safety Services Market by Data Bridge Market Research evaluates market size, trend, and...
TIP_link_300x300.jpg
Cardiac Monitoring Devices Market Size Worth $43.33Bn, Globally, by 2028 at 6.4% CAGR - Exclusive Report by The Insight Partners
April 01, 2022 05:37 ET | The Insight Partners
New York, April 01, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Cardiac Monitoring Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type...
TeleflexLogo.jpg
Teleflex Completes Enrollment in Cardiac IDE Study
October 27, 2021 06:30 ET | Teleflex Incorporated
WAYNE, Pa., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the completion of patient enrollment in a clinical...
researchdrivelogo.jpg
Global Plasma Therapy Market Predicted to Garner a Revenue of $432.8 Million at a CAGR of 16.3% during the Forecast Period, 2019-2026 - Exclusive report by Research Dive
July 26, 2021 09:03 ET | Research Dive
New York, USA, July 26, 2021 (GLOBE NEWSWIRE) -- According to a recent report by Research Dive, the global plasma therapy market is forecasted to reach $432.8 million by the end of 2026, from $131.9...
InCarda Logo.png
InCarda Therapeutics Provides Corporate Update Highlighting New Phase 2 Data for InRhythm™ Program, Plans for Pivotal Phase 3 Study and Expansion of Senior Management Team
June 09, 2021 08:05 ET | InCarda Therapeutics, Inc.
Positive Data from Completed InRhythm Phase 2 Study Demonstrate Safe and Rapid Conversions from Atrial Fibrillation to Normal Sinus Rhythm Plans to Initiate RESTORE1: Single Pivotal Phase 3 Trial in...
ARC logo.png
Cardiac Rehabilitation Market In North America Is Required To Represent Significant Income Share In The Worldwide: Acumen Research And Consulting
May 26, 2021 10:24 ET | Acumen Research and Consulting
LOS ANGELES, May 26, 2021 (GLOBE NEWSWIRE) -- Cardiac rehabilitation is a customized outpatient program which is designed to help you improve your health and recover from a heart attack, other forms...
AMR Logo.png
U.S. Cardiac Resynchronization Therapy Market to Garner $983.3 Million by 2027: AMR
April 06, 2021 10:15 ET | Allied Market Research
PORTLAND, Ore., April 06, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the U.S. Cardiac Resynchronization Therapy Market was pegged at $965.6 million in 2019, and...